Atorvastatin and Pravastatin Elevated Pre-heparin Lipoprotein Lipase Mass of Type 2 Diabetes with Hypercholesterolemia
Author:
Affiliation:
1. The Center of Diabetes, Endocrine and Metabolism, Sakura Hospital, Toho University School of Medicine, Chiba, Japan
Publisher
Japan Atherosclerosis Society
Subject
Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine
Link
https://www.jstage.jst.go.jp/article/jat/11/6/11_6_341/_pdf
Reference22 articles.
1. (1) Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, Mckillop JH, and Packard CJ: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med, 333: 1301−1307, 1995
2. (2) Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L Title LN, Eisenberg D, Shurzinske L, and MacCormick LS: Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med, 341: 70−76,1999
3. (3) Byington RP, Furberg CD, Crouse JR third, Espeland MA, and Bond MG: Pravastatin, Lipids, and atherosclerosis in the carotid arteries (PLAC-II). Am J Cardiol, 76: 54C−59C, 1995
4. (4) Gaw A: Can the clinical efficiency of the HMG-CoA reductase inhibitors be explained solely by their effects on LDL-cholesterol? Atherosclerosis, 125: 267−269, 1996
5. (5) Negre-Aminou P, van Vliet AK, van Erck M, van Thiel GC, van Leeuwen RE, and Cohen LH: Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitor; comparison with other human cell types. Biochim Biophys Acta, 21: 259−268, 1997
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lipoprotein lipase as a target for obesity/diabetes related cardiovascular disease;Journal of Pharmacy & Pharmaceutical Sciences;2024-07-16
2. Correlations between genetically predicted lipid-lowering drug targets and inflammatory bowel disease;Lipids in Health and Disease;2024-01-29
3. Pitavastatin versus Atorvastatin: Potential Differences in their Effects on Serum Lipoprotein Lipase and Cardiovascular Disease;Journal of Atherosclerosis and Thrombosis;2021
4. Prevention of Cardiovascular Events with Pitavastatin is Associated with Increased Serum Lipoprotein Lipase Mass Level: Subgroup Analysis of the TOHO-LIP;Journal of Atherosclerosis and Thrombosis;2021
5. Serum Triglyceride Lipase Concentrations are Independent Risk Factors for Coronary Artery Disease and In-Stent Restenosis;Journal of Atherosclerosis and Thrombosis;2019-09-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3